DDD Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-199,946
Closed -$18.4M 91
2023
Q1
$18.4M Buy
199,946
+1,965
+1% +$172K 2.87% 10
2022
Q4
$18M Buy
197,981
+4,047
+2% +$341K 2.87% 14
2022
Q3
$14.7M Buy
193,934
+35,985
+23% +$2.98M 2.67% 13
2022
Q2
$13.4M Buy
157,949
+1,989
+1% +$174K 2.32% 19
2022
Q1
$13.7M Buy
155,960
+2,738
+2% +$237K 1.87% 26
2021
Q4
$13.4M Buy
153,222
+2,285
+2% +$190K 1.84% 22
2021
Q3
$12.3M Buy
150,937
+1,365
+0.9% +$123K 1.85% 22
2021
Q2
$13.6M Buy
149,572
+4,177
+3% +$372K 2.07% 20
2021
Q1
$12.4M Buy
145,395
+2,713
+2% +$243K 2.12% 17
2020
Q4
$13.5M Buy
142,682
+6,733
+5% +$588K 2.66% 16
2020
Q3
$11.8M Buy
135,949
+18,659
+16% +$1.62M 3.07% 15
2020
Q2
$10.2M Buy
117,290
+11,786
+11% +$1.02M 2.94% 19
2020
Q1
$8.7M Buy
105,504
+3,819
+4% +$341K 3.02% 15
2019
Q4
$9.63M Sell
101,685
-1,895
-2% -$170K 2.66% 20
2019
Q3
$9M Sell
103,580
-191
-0.2% -$17.1K 2.76% 17
2019
Q2
$9.47M Sell
103,771
-11,796
-10% -$998K 3.03% 14
2019
Q1
$9.96M Buy
115,567
+1,279
+1% +$103K 3.42% 13
2018
Q4
$8.79M Buy
114,288
+421
+0.4% +$32.8K 3.28% 13
2018
Q3
$8.79M Buy
113,867
+999
+0.9% +$73.9K 3.12% 16
2018
Q2
$7.64M Buy
112,868
+1,636
+1% +$113K 3.11% 16
2018
Q1
$8.06M Buy
111,232
+3,122
+3% +$238K 3.25% 15
2017
Q4
$8.13M Buy
+108,110
New +$8.16M 3.16% 15

Other funds holding NVS

DDD Partners's NVS Position: Q2 2023 in Review

DDD Partners sold out of Novartis (NVS) in Q2 2023, closing a stake of 199,946 shares — an estimated $18.4M sold.

DDD Partners first reported a position in NVS in Q4 2017 and held it in 22 quarters. The position peaked at $18.4M in Q1 2023. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

  • DDD Partners reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
  • DDD Partners sold 199,946 Novartis shares in Q2 2023, an estimated $18.4M.
  • DDD Partners first reported a position in Novartis in Q4 2017 and held it in 22 quarters.
  • DDD Partners's Novartis position peaked at $18.4M in Q1 2023.
  • 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on DDD Partners's 13F filing for Q2 2023, filed 2 Aug 2023.